HB+ is proud to partner with the National Minority Health Association to help bring about health equity and close the disparity gap in health and healthcare for underserved, marginalized, hard-to-reach, and minority communities.

A real-world study of the recombinant zoster vaccine (RZV) found that two doses provided strong and lasting protection against herpes zoster , or shingles, even in patients at higher risk for the disease , such as those taking corticosteroids. The findings are published in Annals of Internal Medicine.

Read More